Product Images Lyrica
View Photos of Packaging, Labels & Appearance
- PRINCIPAL DISPLAY PANELNDC: 42549-612-30Lyrica 75mg #30 tablets - LYRICA 50 MG C V 42549
- PRINCIPAL DISPLAY PANEL - LYRICA 75 MG C V 42549
- Figure of the Cockcroft and Gault equation - lyrica 1
- Figure 8: Patients Achieving Various Levels of Pain Relief – Fibromyalgia Study F1 - lyrica 10
- Figure 9: Time to Loss of Therapeutic Response, Fibromyalgia Study F2 (Kaplan-Meier Analysis) - lyrica 11
- The chemical structure of pregabalin. - lyrica 2
- Figure 1: Patients Achieving Various Levels of Pain Relief – Study DPN 1 - lyrica 3
- Figure 2: Patients Achieving Various Levels of Pain Relief – Study DPN 2 - lyrica 4
- Figure 3: Patients Achieving Various Levels of Pain Relief – Study PHN 1 - lyrica 5
- Figure 4: Patients Achieving Various Levels of Pain Relief – Study PHN 2 - lyrica 6
- Figure 5: Patients Achieving Various Levels of Pain Relief – Study PHN 3 - lyrica 7
- Figure 6. Responder rate by add-on epilepsy study - lyrica 8
- Figure 7. Seizure Reduction by Dose (All Partial Onset Seizures) for Studies E1, E2, and E3 - lyrica 9
Product Label Images
The following 13 images provide visual information about the product associated with Lyrica NDC 42549-660 by Stat Rx Usa Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
PRINCIPAL DISPLAY PANELNDC: 42549-612-30Lyrica 75mg #30 tablets - LYRICA 50 MG C V 42549
PRINCIPAL DISPLAY PANEL - LYRICA 75 MG C V 42549
This is a medication label for Duroea containing Pregabalin 75mg per capsule. It also lists the NDC number, lot number, and discard date. The label is from a pharmacy in Gainesville.*
Figure of the Cockcroft and Gault equation - lyrica 1
This text appears to be a formula, possibly related to calculating the creatinine clearance rate for female patients. It involves using the person's age (in years) subtracted from 140, multiplying their weight (in kilograms) by 5, and then multiplying their serum creatinine (in mg/dL) by 72. There is also a notation about the clearance rate being 85% for female patients.*
Figure 8: Patients Achieving Various Levels of Pain Relief – Fibromyalgia Study F1 - lyrica 10
Figure 9: Time to Loss of Therapeutic Response, Fibromyalgia Study F2 (Kaplan-Meier Analysis) - lyrica 11
The chemical structure of pregabalin. - lyrica 2
Figure 1: Patients Achieving Various Levels of Pain Relief – Study DPN 1 - lyrica 3
Figure 2: Patients Achieving Various Levels of Pain Relief – Study DPN 2 - lyrica 4
Figure 3: Patients Achieving Various Levels of Pain Relief – Study PHN 1 - lyrica 5
Figure 4: Patients Achieving Various Levels of Pain Relief – Study PHN 2 - lyrica 6
Figure 5: Patients Achieving Various Levels of Pain Relief – Study PHN 3 - lyrica 7
This text is not available.*
Figure 6. Responder rate by add-on epilepsy study - lyrica 8
Figure 7. Seizure Reduction by Dose (All Partial Onset Seizures) for Studies E1, E2, and E3 - lyrica 9
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
